18F-fluoro-2-deoxy-2-d-glucose PET-CT (FDG PET-CT) in staging of high-risk renal and urothelial bladder cancers (COPPER-T) trial protocol.
Rahul JenaBhargava PriyankShashank TripathiSameer TaywadeTaruna YadavArjun Singh SandhuMahendra SinghShiv Charan NavriyaDeepak Prakash BhirudAmit AggarwalGautam Ram ChoudharyPublished in: BJUI compass (2023)
Final analysis of the data after completion of the trial will help in clarifying the role of FDG PET-CT in high risk RCC and transitional cell carcinoma (TCC) of the bladder, its diagnostic accuracy compared with conventional imaging and the impact of using it on patient management.
Keyphrases
- pet ct
- positron emission tomography
- urinary tract
- study protocol
- phase iii
- spinal cord injury
- phase ii
- clinical trial
- randomized controlled trial
- high resolution
- case report
- lymph node
- open label
- electronic health record
- renal cell carcinoma
- machine learning
- adipose tissue
- skeletal muscle
- mass spectrometry
- data analysis
- photodynamic therapy